Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-25-000004
Filing Date
2025-01-24
Accepted
2025-01-24 06:34:33
Documents
25
Period of Report
2025-01-24

Document Format Files

Seq Description Document Type Size
1 6-K a2025-01x22appendix2a3y.htm 6-K 25855
2 EX-99.1 exhibit991.htm EX-99.1 5428
3 EX-99.2 exhibit992.htm EX-99.2 4882
4 EX-99.3 exhibit993.htm EX-99.3 1989
5 EX-99.4 exhibit994.htm EX-99.4 6164
6 exhibit991001.jpg GRAPHIC 78203
7 exhibit991002.jpg GRAPHIC 62931
8 exhibit991003.jpg GRAPHIC 83516
9 exhibit991004.jpg GRAPHIC 79181
10 exhibit991005.jpg GRAPHIC 99790
11 exhibit992001.jpg GRAPHIC 141384
12 exhibit992002.jpg GRAPHIC 124516
13 exhibit992003.jpg GRAPHIC 39215
14 exhibit993001.jpg GRAPHIC 78524
15 exhibit993002.jpg GRAPHIC 63012
16 exhibit993003.jpg GRAPHIC 83254
17 exhibit993004.jpg GRAPHIC 82664
18 exhibit993005.jpg GRAPHIC 63639
19 exhibit993006.jpg GRAPHIC 99880
20 exhibit994001.jpg GRAPHIC 71744
21 exhibit994002.jpg GRAPHIC 57335
22 exhibit994003.jpg GRAPHIC 66057
23 exhibit994004.jpg GRAPHIC 77308
24 exhibit994005.jpg GRAPHIC 58319
25 exhibit994006.jpg GRAPHIC 92953
  Complete submission text file 0001345099-25-000004.txt   2254680
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 25551590
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)